TGTX•benzinga•
FUJIFILM Diosynth Biotechnologies Announces That TG Therapeutics Has Committed To A Multi-Year Manufacturing Supply Agreement For BRIUMVI, Its U.S. FDA-Approved Therapeutic For Relapsing Forms Of Multiple Sclerosis
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 4, 2024 by benzinga